Smoking cessation toolbox for allergists.
OBJECTIVE
To review nicotine addiction, to examine how tobacco use has a direct negative impact on common disorders seen in allergy practice, and to provide a summary of the national guidelines for treating tobacco use and dependence.


METHODS
OVID searches were performed cross-referencing the keywords tobacco cessation, tobacco use, environmental tobacco exposure, and smoking with multiple disorders commonly seen in allergy practice. References of the chosen articles were also examined.


METHODS
Articles were selected based on their relevance to the subject matter and currency.


RESULTS
The current US smoking rate far exceeds the desired national goal established by Healthy People 2010. Efforts have been made by the US Public Health Department to streamline the treatment of smoking use and dependence for all physicians. Published research strongly supports the negative impact smoking has on asthma, chronic rhinitis, allergic sensitization, and immunodeficiency disorders.


CONCLUSIONS
Allergists know the significant impact that smoking has and will make on the lives and health of patients. It is important for these specialists to make an impact on the chronic disease of tobacco addiction because it directly affects the care rendered. By using the standardized tobacco use treatment concept of the 5 A's (ask, advise, assess, assist, and arrange), allergists can make a positive impact on reducing US smoking rates and improve patient health. Screening, providing brief counseling, and prescribing first-line smoking cessation medications will help the United States get closer to achieving the national goal laid out in Healthy People 2010 of smoking rates of 12% or less.
Department of Allergy and Immunology, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas, USA. kimberly.johnson@lackland.af.mil
Kimberly S
KS
Johnson
Michael S
MS
Tankersley
D000486:Allergy and Immunology; D006801:Humans; D010353:Patient Education as Topic; D010820:Physicians; D012907:Smoking / Q000009:adverse effects; D016540:Smoking Cessation / Q000379:methods*; D014029:Tobacco Use Disorder / Q000276:immunology